10561254

Source:http://linkedlifedata.com/resource/pubmed/id/10561254

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016384, umls-concept:C0120107, umls-concept:C0285590, umls-concept:C0337810, umls-concept:C0376358, umls-concept:C1274040, umls-concept:C1516213, umls-concept:C1709701, umls-concept:C2603343
pubmed:issue	7
pubmed:dateCreated	2000-6-7
pubmed:abstractText	To compare the efficacy of bicalutamide monotherapy to maximal androgen blockade (MAB) in the treatment of advanced prostatic cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10561254-10637263
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anilides, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Flutamide, http://linkedlifedata.com/resource/pubmed/chemical/Goserelin, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/Tosyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/bicalutamide
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0732-183X
pubmed:author	pubmed-author:BarichelloMM, pubmed-author:BattagliaMM, pubmed-author:BoccardiLL, pubmed-author:CarmignaniGG, pubmed-author:ComeriGG, pubmed-author:ContiGG, pubmed-author:CrucianiGG, pubmed-author:DamminoSS, pubmed-author:DellipontiUU, pubmed-author:DitonnoPP, pubmed-author:FerrarisVV, pubmed-author:LilliuSS, pubmed-author:MontefioreFF, pubmed-author:PortogheseFF, pubmed-author:RubagottiAA, pubmed-author:SpanoGG
pubmed:issnType	Print
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2027-38
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:10561254-Adult, pubmed-meshheading:10561254-Aged, pubmed-meshheading:10561254-Aged, 80 and over, pubmed-meshheading:10561254-Anilides, pubmed-meshheading:10561254-Antineoplastic Agents, pubmed-meshheading:10561254-Antineoplastic Agents, Hormonal, pubmed-meshheading:10561254-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10561254-Consumer Product Safety, pubmed-meshheading:10561254-Disease Progression, pubmed-meshheading:10561254-Disease-Free Survival, pubmed-meshheading:10561254-Erectile Dysfunction, pubmed-meshheading:10561254-Flutamide, pubmed-meshheading:10561254-Goserelin, pubmed-meshheading:10561254-Humans, pubmed-meshheading:10561254-Italy, pubmed-meshheading:10561254-Male, pubmed-meshheading:10561254-Middle Aged, pubmed-meshheading:10561254-Nitriles, pubmed-meshheading:10561254-Proportional Hazards Models, pubmed-meshheading:10561254-Prostatic Neoplasms, pubmed-meshheading:10561254-Quality of Life, pubmed-meshheading:10561254-Survival Rate, pubmed-meshheading:10561254-Tosyl Compounds
pubmed:year	1999
pubmed:articleTitle	Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
pubmed:affiliation	Department of Medical Oncology and Biostatistics Unit, University and National Cancer Institute, Genoa, Italy.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study